Intralesional Diode Laser 1064 Nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients

Overview

Journal Open Access Maced J Med Sci

Specialty General Medicine

Date 2018 Feb 28

PMID 29483975

Citations 3

Authors

Gabriella Fabbrocini

Katlein Franca

Torello Lotti

Claudio Marasca

Maria Carmela Annunziata

Sara Cacciapuoti

Anna Masara

Marco Romanelli

Jacopo Lotti

Uwe Wollina

Georgi Tchernev

Nicola Zerbinati

Affiliations

Soon will be listed here.

Abstract

Aim: Hidradenitis suppurativa (HS) is a chronic inflammatory disease, commonly characterized by painful, deep dermal abscesses and chronic draining sinus tracts. Recently, laser and light-based therapies have become more commonly used in the management of HS.

Material And Methods: We report 20 HS patients treated with a 1064 nm wavelength, emitted from a diode laser, launched in an optical fibre through intracavitary modalities.

Results: Each patient underwent four laser sessions, one every two weeks. we recorded a significative reduction (31%) of Sartorius score from 28.55 ± 13.04 to 19.75 ± 12.29 after 4 laser sessions (p < 0.05). No one has had a worsening of the disease.

Conclusion: Intralesional diode laser 1064 nm can be a good treatment option for patients with moderate and localized hidradenitis suppurativa, because it is minimally invasive, doesn't have significant complications and provides a rapid post-treatment recovery.

Citing Articles

808 nm diode laser in the treatment of Hidradenitis Suppurativa: a retrospective study.

Ozdemir A, Tamer E Arch Dermatol Res. 2024; 316(10):708.

PMID: 39528770 DOI: 10.1007/s00403-024-03472-5.

The Current Clinical Trial Landscape for Hidradenitis Suppurativa: A Narrative Review.

Hunt A, Qian V, Olds H, Daveluy S Dermatol Ther (Heidelb). 2023; 13(7):1391-1407.

PMID: 37261652 PMC: 10307738. DOI: 10.1007/s13555-023-00935-x.

Laser and Light-Based Treatment Modalities for the Management of Hidradenitis Suppurativa.

Lyons A, Townsend S, Turk D, Narla S, Baah N, Hamzavi I Am J Clin Dermatol. 2019; 21(2):237-243.

PMID: 31845121 DOI: 10.1007/s40257-019-00491-1.

References

Kimball A, Kerdel F, Adams D, Mrowietz U, Gelfand J, Gniadecki R . Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012; 157(12):846-55. DOI: 10.7326/0003-4819-157-12-201212180-00004. View

Finlay A, Khan G . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. View

Scuderi N, Monfrecola A, Dessy L, Fabbrocini G, Megna M, Monfrecola G . Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review. Skin Appendage Disord. 2017; 3(2):95-110. PMC: 5436059. DOI: 10.1159/000462979. View

Naik H . Hidradenitis suppurativa, introduction. Semin Cutan Med Surg. 2017; 36(2):41. DOI: 10.12788/j.sder.2017.025. View

Agut-Busquet E, Romani J, Gilaberte Y, Garcia-Malinis A, Ribera-Pibernat M, Luelmo J . Photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective follow-up study in 7 patients and a review of the literature. Photochem Photobiol Sci. 2016; 15(8):1020-8. DOI: 10.1039/c6pp00082g. View

John H, Manoloudakis N, Stephen Sinclair J . A systematic review of the use of lasers for the treatment of hidradenitis suppurativa. J Plast Reconstr Aesthet Surg. 2016; 69(10):1374-81. DOI: 10.1016/j.bjps.2016.05.029. View

Hamzavi I, Griffith J, Riyaz F, Hessam S, Bechara F . Laser and light-based treatment options for hidradenitis suppurativa. J Am Acad Dermatol. 2015; 73(5 Suppl 1):S78-81. DOI: 10.1016/j.jaad.2015.07.050. View

Hoffman L, Ghias M, Garg A, Hamzavi I, Alavi A, Lowes M . Major gaps in understanding and treatment of hidradenitis suppurativa. Semin Cutan Med Surg. 2017; 36(2):86-92. DOI: 10.12788/j.sder.2017.024. View

Zerbinati N, DEste E, Ini L, Baruffato A, Premoli V, Calligaro A . Clinical and histological changes in Hidradenitis suppurativa following 1064 nm nd:YAG intralesional laser treatment. J Biol Regul Homeost Agents. 2017; 31(2 Suppl. 2):131-140. View

10.

Sehgal V, Verma P, Sawant S, Paul M . Contemporary surgical treatment of hidradenitis suppurativa (HS) with a focus on the use of the diode hair laser in a case. J Cosmet Laser Ther. 2011; 13(4):180-90. DOI: 10.3109/14764172.2011.594066. View

11.

Xu L, Wright D, Mahmoud B, Ozog D, Mehregan D, Hamzavi I . Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment. Arch Dermatol. 2010; 147(1):21-8. DOI: 10.1001/archdermatol.2010.245. View

12.

Orenstein L, Micheletti R . Medical management of hidradenitis suppurativa. Semin Cutan Med Surg. 2017; 36(2):62-66. DOI: 10.12788/j.sder.2017.021. View

13.

Kimball A, Sobell J, Zouboulis C, Gu Y, Williams D, Sundaram M . HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study. J Eur Acad Dermatol Venereol. 2015; 30(6):989-94. PMC: 5034809. DOI: 10.1111/jdv.13216. View

14.

Valladares-Narganes L, Rodriguez-Prieto M, Blanco-Suarez M, Rodriguez-Lage C, Garcia-Doval I . Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach. Br J Dermatol. 2014; 172(4):1136-9. DOI: 10.1111/bjd.13385. View

15.

Sartorius K, Lapins J, Emtestam L, Jemec G . Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003; 149(1):211-3. DOI: 10.1046/j.1365-2133.2003.05390.x. View

16.

Downs A . Smoothbeam laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease. J Cosmet Laser Ther. 2004; 6(3):163-4. DOI: 10.1080/14764170410003002. View